Thymosin Alpha-1 vs LL-37
A comprehensive side-by-side comparison of Thymosin Alpha-1 and LL-37 covering mechanisms, benefits, dosing, and safety.
Quick Verdict
Thymosin Alpha-1 enhances adaptive immunity through T-cell maturation and modulation, while LL-37 is a cathelicidin antimicrobial peptide that provides innate immune defense. They address different arms of the immune system.
Thymosin Alpha-1
Thymosin Alpha-1 is a peptide naturally produced by the thymus gland. It plays a crucial role in immune system regulation and has been approved in many countries for treatment of hepatitis B and C, and as an adjunct to cancer therapy.
View Full ProfileLL-37
LL-37 is the only cathelicidin-derived antimicrobial peptide found in humans. It is a 37-amino-acid peptide cleaved from the C-terminal end of the human cathelicidin protein hCAP18. LL-37 plays a central role in innate immune defense against bacterial, viral, and fungal infections.
View Full ProfileAt a Glance
Mechanism of Action
Thymosin Alpha-1
Thymosin Alpha-1 enhances T-cell function, promotes T-cell maturation, and modulates cytokine production. It activates dendritic cells, increases natural killer cell activity, and helps restore immune balance in immunocompromised states.
LL-37
LL-37 disrupts microbial membranes through electrostatic interactions with negatively charged lipid bilayers. Beyond direct antimicrobial activity, it modulates the immune response by promoting chemotaxis of immune cells, stimulating angiogenesis, enhancing wound healing, and modulating inflammatory cytokine production. It can also neutralize bacterial endotoxins (LPS).
Potential Benefits
Thymosin Alpha-1
- + Enhanced immune function
- + Improved T-cell activity
- + Vaccine adjuvant effects
- + Antiviral properties
- + Cancer support
LL-37
- + Broad-spectrum antimicrobial activity
- + Enhanced innate immune response
- + Accelerated wound healing
- + Biofilm disruption capability
- + Immune modulation and LPS neutralization
Side Effects
Thymosin Alpha-1
- ! Injection site reactions
- ! Transient fever (rare)
- ! Generally very well tolerated
LL-37
- ! Injection site irritation
- ! Local inflammatory response at high doses
- ! Limited human safety data for systemic use
- ! Potential mast cell activation at high concentrations
Research Areas
Thymosin Alpha-1
LL-37
Frequently Asked Questions
Is Thymosin Alpha-1 or LL-37 better for immunity?
They serve different immune functions. Thymosin Alpha-1 enhances the adaptive immune system by promoting T-cell maturation and function. LL-37 is a natural antimicrobial peptide that directly kills pathogens and modulates innate immune responses. They can be complementary.
Can Thymosin Alpha-1 and LL-37 be used together?
Yes, they target different arms of the immune system and can be complementary. Thymosin Alpha-1 addresses adaptive immunity while LL-37 strengthens innate defenses. This combination is used in comprehensive immune support protocols.
Related Comparisons
Explore These Peptides
Learn more about each peptide or find optimized stacking protocols.